SHE:301246 - Hubei Hongyuan Pharmaceutical Technology Co Ltd

Hubei Hongyuan Pharmaceutical
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	0% -	0% -	0% -	-	60.84% -
Net Margin	[friend]	[friend]	[friend]	31.95% 30.3%	47.87% 49.8%	23.36% -51.2%	39.19% 67.8%	27.93% -28.7%	16.15% -42.2%	8.54% -47.1%	12.85% 50.4%	0.06% -99.6%	5.57% 9766.2%	-1.84% -	7.32% -
Gross Margin	[friend]	[friend]	[friend]	-23.22% -	220.52% -	-105.21% -	31.61% -	21.87% -30.8%	18.63% -14.8%	21.88% 17.5%	19.28% -11.9%	9.65% -49.9%	14.7% 52.3%	7.97% -45.8%	15.73% 97.3%
Operating Margin	[friend]	[friend]	[friend]	-45.15% -	241.97% -	-135.82% -	24.52% -	15.29% -37.7%	10.65% -30.3%	14.29% 34.1%	17.09% 19.6%	0.07% -99.6%	6.85% 9136.8%	-2.95% -	8.25% -
Total Revenue	[friend]	[friend]	[friend]	360.77M 6.7%	368.84M 2.2%	510.28M 38.3%	451.16M -11.6%	450.16M -0.2%	433.18M -3.8%	729.22M 68.3%	503.91M -30.9%	493.72M -2.0%	561.08M 13.6%	496.17M -11.6%	426.06M -14.1%
Total Assets	[friend]	[friend]	[friend]	1.94B -	2.2B 13.6%	2.43B 10.5%	2.95B 21.4%	3.29B 11.3%	3.56B 8.4%	3.88B 8.8%	5.95B 53.4%	5.71B -4.0%	5.56B -2.6%	5.65B 1.6%	5.64B -0.2%
Total Liabilities	[friend]	[friend]	[friend]	555.65M -	642.71M 15.7%	754.27M 17.4%	1.1B 45.5%	1.3B 18.9%	1.51B 15.7%	1.76B 16.7%	1.57B -10.8%	1.37B -12.6%	1.19B -13.3%	1.29B 8.4%	1.25B -3.3%
Total Equity	[friend]	[friend]	[friend]	1.38B -	1.56B 12.7%	1.68B 7.6%	1.85B 10.5%	1.98B 6.8%	2.05B 3.5%	2.11B 3.1%	4.38B 107.0%	4.34B -0.9%	4.37B 0.8%	4.36B -0.2%	4.39B 0.7%
Operating CashFlow	[friend]	[friend]	[friend]	106.92M -	-	-	-	112.41M -	-	-	-	-110.28M -	-	-	-
Beginning Cash Position	[friend]	[friend]	[friend]	224.27M -	-	-	95.78M -	297.89M 211.0%	328.93M 10.4%	295.7M -10.1%	236.72M -19.9%	2.33B 883.5%	193.28M -91.7%	822.86M 325.7%	356.4M -56.7%
End Cash Position	[friend]	[friend]	[friend]	140.08M -	-	-	297.89M -	328.93M 10.4%	295.7M -10.1%	236.72M -19.9%	2.33B 883.5%	193.28M -91.7%	822.86M 325.7%	356.4M -56.7%	521.97M 46.5%
Free Cash Flow	[friend]	[friend]	[friend]	-47.8M -	124.27M -	-193.63M -	-65.96M -	-178.19M -	-26.36M -	-21.59M -	-113.47M -	-162.45M -	118.45M -	-281.92M -	-222.01M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	198.11M -	-	-	-	302.54M -	-	-	-	65.02M -	-	-	-
Diluted Net Income	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	0.327 39.1%	0.501 53.2%	0.338 -32.5%	0.5 48.0%	0.295 -41.0%	0.261 -11.5%	0.177 -32.4%	0.179 1.5%	-0.008 -	0.08 -	-0.026 -	0.078 -
Return On Equity (%)	[friend]	[friend]	[friend]	8.33% -	12% 44.0%	7.36% -38.6%	10.01% 35.9%	6.56% -34.5%	3.47% -47.1%	2.99% -13.8%	2% -33.3%	0.01% -99.7%	0.72% 11126.6%	-0.21% -	0.71% -
Return On Assets (%)	[friend]	[friend]	[friend]	5.95% -	8.53% 43.4%	5.14% -39.7%	6.57% 27.7%	4.03% -38.6%	2.04% -49.3%	1.68% -18.0%	1.32% -21.3%	0% -99.6%	0.56% 11462.5%	-0.16% -	0.55% -